KalVista Pharmaceuticals, Inc.
USD26.95
+0.01 (+0.04%)
CEO
Benjamin L. Palleiko
IPO Date
2015-04-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$26.95
Prev. Close
$26.94
Day Low
$26.94
Day High
$26.96
52W Low
$9.83
52W High
$26.98
Market Cap
$1.43B
Volume
6.43M
| 33,800 |
| $26.78 |
| 29 May 2026 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M-Exempt | Disposed | 33,800 | $7.07 |
| 27 May 2026 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M-Exempt | Acquired | 3,125 | $0.00 |
| 27 May 2026 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | S-Sale | Disposed | 1,966 | $26.78 |
| 27 May 2026 | Yea Christopher | CHIEF DEVELOPMENT OFFICER | M-Exempt | Disposed | 3,125 | $0.00 |
| 27 May 2026 | Sweeny Nicole | Chief Commercial Officer | M-Exempt | Acquired | 5,000 | $0.00 |
| 27 May 2026 | Sweeny Nicole | Chief Commercial Officer | S-Sale | Disposed | 1,489 | $26.78 |
| 27 May 2026 | Sweeny Nicole | Chief Commercial Officer | M-Exempt | Disposed | 5,000 | $0.00 |
| 27 May 2026 | Audhya Paul K. | CHIEF MEDICAL OFFICER | M-Exempt | Acquired | 5,000 | $0.00 |